SS

Shubhada Shirgaonkar

Active Director Additional Director DIN 11128669
DIN 11128669 First appointment May 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubhada Shirgaonkar

Data last updated:

Shubhada Shirgaonkar is an Additional Director at Capragen Biotech Private Limited (since 2025). The company operates in Chemicals.

DIN 11128669
Primary Designation Additional Director
Industry Chemicals
First Appointment 29 May 2025
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Capragen Biotech Private Limited U24299MH2020PTC341601
Additional Director29 May 20252020Active

Board colleagues of Shubhada Shirgaonkar

NameDINCompanyDesignation
Dattaram Shirgaonkar08786356Capragen Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Capragen Biotech Private Limited
Premium access

Shareholding and investment profile for Shubhada Shirgaonkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhada Shirgaonkar

Shubhada Shirgaonkar currently holds 1 directorship: Capragen Biotech Private Limited (Additional Director, since 29 May 2025).

Shubhada Shirgaonkar was first appointed on 29 May 2025 as Additional Director at Capragen Biotech Private Limited.

The current boards of Shubhada Shirgaonkar's companies include Dattaram Shirgaonkar (Capragen Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available